Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

C. Oliver Hanemann^*, Sylwia Ammoun, D. Gareth Evans, David A. Hilton, Adam Streeter, Christopher Hayward

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Journal of Neurology, Neurosurgery and Psychiatry
Volume	0
Issue number	0
Early online date	4 Feb 2019
DOIs	https://doi.org/10.1136/jnnp-2018-319713
Publication status	Published - 4 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2ef1ba41c79646439418bc092bb369b8,

title = "Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2",

author = "Hanemann, {C. Oliver} and Sylwia Ammoun and Evans, {D. Gareth} and Hilton, {David A.} and Adam Streeter and Christopher Hayward",

year = "2019",

month = feb,

day = "4",

doi = "10.1136/jnnp-2018-319713",

language = "English",

volume = "0",

journal = "Journal of Neurology, Neurosurgery and Psychiatry",

issn = "0022-3050",

publisher = "BMJ Publishing Group",

number = "0",

}

TY - JOUR

T1 - Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

AU - Hanemann, C. Oliver

AU - Ammoun, Sylwia

AU - Evans, D. Gareth

AU - Hilton, David A.

AU - Streeter, Adam

AU - Hayward, Christopher

PY - 2019/2/4

Y1 - 2019/2/4

U2 - 10.1136/jnnp-2018-319713

DO - 10.1136/jnnp-2018-319713

M3 - Article

SN - 0022-3050

VL - 0

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

IS - 0

ER -